best performing stocks 2017-2022

Altimmune (ALT) had the highest return between 2017 and 2022 by a US stock, returning 8,224,900%.

ASSETYEARS% RETURN
Altimmune (ALT)
2017-2022
8,224,900%
Lexaria Bioscience (LEXX)
2017-2022
2,635,614.29%
MDxHealth (MDXH)
2017-2022
1,321,900%
Addex Therapeutics (ADXN)
2017-2022
699,900%
Nocera (NCRA)
2017-2022
533,233.33%
Addentax (ATXG)
2017-2022
321,500%
Immatics (IMTX)
2017-2022
174,100%
Integra Resources (ITRG)
2017-2022
126,500%
SurgePays (SURG)
2017-2022
117,042.86%
A2Z Smart Technologies (AZ)
2017-2022
85,710.81%
Change Agents (CHGA)
2017-2022
62,300%
Lunai Bioworks (LNAI)
2017-2022
46,718.18%
authID (AUID)
2017-2022
30,780%
Bone Biologics (BBLG)
2017-2022
27,143.24%
Enphase Energy (ENPH)
2017-2022
25,876.47%
Guardforce AI (GFAI)
2017-2022
24,323.08%
FingerMotion (FNGR)
2017-2022
22,380%
Electra Battery Materials (ELBM)
2017-2022
18,141.76%
Reliance Global (EZRA)
2017-2022
14,281.99%
Artelo Biosciences (ARTL)
2017-2022
11,604.5%
AquaBounty Technologies (AQB)
2017-2022
10,511.11%
Beyond Air (XAIR)
2017-2022
8,553.33%
American Resources Corp Class A (AREC)
2017-2022
7,826.22%
Alarum Technologies (ALAR)
2017-2022
6,979.65%
FitLife Brands, Inc Common Stock (FTLF)
2017-2022
6,618.62%